Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Apolipoprotein E receptor" refers to a group of cell-surface receptors that bind apolipoprotein E (apoE), a key protein involved in lipid metabolism, neuronal maintenance, and neurodegenerative disease processes. These receptors are primarily members of the low-density lipoprotein receptor (LDLR) family and play essential roles in mediating the uptake and cellular effects of apoE-containing lipoproteins. Major receptor types include LDLR, LRP1, VLDLR, ApoER2/LRP8, and Heparan Sulfate Proteoglycans. They are involved in various biological functions such as mediating endocytosis/clearance of triglyceride-rich lipoproteins, regulating cholesterol transport, facilitating cholesterol delivery in the CNS, modulating cellular processes, and influencing susceptibility to neurodegenerative diseases. Dysfunction or altered expression contribute to hyperlipidemias, atherosclerosis, and neurodegenerative disorders including Alzheimer's disease. Recent research highlights potential therapeutic targeting opportunities.
Enhancing protective signaling via APOER2; modulating amyloid beta deposition/toxicity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein E Receptor (ApoE Receptor).